GASTROINTESTINAL AND ABDOMINAL RADIOLOGY / CASE REPORT
Rare complications of Crohn’s disease – a series of three cases
1
Military Institute of Aviation Medicine, Warsaw, Poland
2
Department of Radiology and Diagnostic Imaging, Central Teaching Hospital of the Medical University of Lodz, Poland
3
II Department of Radiology and Diagnostic Imaging, Medical University of Lodz, Poland
4
Department of Gastroenterology and Internal Medicine, Central Teaching Hospital of the Medical University of Lodz, Poland
5
Department of Gastroenterology, Medical University of Lodz, Poland
Submission date: 2025-04-10
Final revision date: 2025-04-14
Acceptance date: 2025-04-15
Publication date: 2025-07-18
Corresponding author
Filip Kwiatkowski
Military Institute of Aviation Medicine, Krasińskiego 54/56 Street, 01-755 Warsaw, Poland
Military Institute of Aviation Medicine, Krasińskiego 54/56 Street, 01-755 Warsaw, Poland
Pol J Radiol, 2025; 90: 367-373
KEYWORDS
TOPICS
ABSTRACT
Crohn’s disease (CD) is an increasingly common disease in clinical practice. The progress of medicine, which has resulted in an extension of the survival time of patients, the introduction of new treatment methods, and the nature of the disease itself means that we are seeing more and more new, unusual complications of this disease.
We have reviewed three cases of rare complications of CD, with a focus on possible atypical complications that may be seen on imaging studies.
Complications of CD and its treatment can occur in various organs and systems, and manifest in very non-specific ways. If unnoticed, they can be even life-threatening; therefore, it is important in clinical practice to take into account the possibility of their presence when evaluating patients with CD.
When assessing radiological examinations of these people, we should take into account the possibility of atypical signs and radiographic features, and consider whether they may be related to the underlying disease.
REFERENCES (40)
1.
Torres J, Mehandru S, Colombel JF, Peyrin-Biroulet L. Crohn’s disease. Lancet 2017; 389: 1741-1755.
2.
Gajendran M, Loganathan P, Catinella AP, Hashash JG. A comprehensive review and update on Crohn’s disease. Dis Mon 2018; 64: 20-57.
3.
Peyrin-Biroulet L, Loftus EV, Colombel JF, Sandborn WJ. Long-term complications, extraintestinal manifestations, and mortality in adult Crohn’s disease in population-based cohorts. Inflamm Bowel Dis 2011; 17: 471-478.
4.
Simoes CC, Ghouri YA, Merwat SN, Stevenson HL. Budd-Chiari syndrome: a rare and life-threatening complication of Crohn’s disease. BMJ Case Rep 2018; bcr-2017-222946. DOI: 10.1136/bcr-2017-222946.
5.
Sáez-González E, Salavert M, Cerrillo E, Moret I, Iborra M, Nos P, et al. Secondary haemophagocytic syndrome and overlapping immune reconstitution syndrome: life-threatening complications of anti-TNF-α treatment for Crohn’s disease. Am J Gastroenterol 2019; 114: 177-179.
6.
Thia KT, Sandborn WJ, Harmsen WS, Zinsmeister AR, Loftus EV Jr. Risk factors associated with progression to intestinal complications of Crohn’s disease in a population-based cohort. Gastroenterology 2010; 139: 1147-1155.
7.
Flynn S, Eisenstein S. Inflammatory bowel disease presentation and diagnosis. Surg Clin North Am 2019; 99: 1051-1062.
8.
Roda G, Chien Ng S, Kotze PG, Argollo M, Panaccione R, Spinelli A, et al. Crohn’s disease. Nat Rev Dis Primers 2020; 6. DOI: 10.1038/s41572-020-0156-2.
9.
Yu YR, Rodriguez JR. Clinical presentation of Crohn’s, ulcerative colitis, and indeterminate colitis: symptoms, extraintestinal manifestations, and disease phenotypes. Semin Pediatr Surg 2017; 26: 349-355.
10.
Veauthier B, Hornecker JR. Crohn’s disease: diagnosis and management. Am Fam Physician 2018; 98: 661-669.
11.
Tonolini M, Villa C, Campari A, Ravelli A, Bianco R, Cornalba G. Common and unusual urogenital Crohn’s disease complications: spectrum of cross-sectional imaging findings. Abdom Imaging 2013; 38: 32-41.
12.
Mazziotti S, Ascenti G, Scribano E, Gaeta M, Pandolfo A, Bombaci F, et al. Guide to magnetic resonance in Crohn’s disease: From common findings to the more rare complicances. Inflamm Bowel Dis 2011; 17: 1209-1222.
13.
Yuya A, Yosuke O, Azusa S. Posterior reversible encephalopathy syndrome: a review of the literarure. Intern Med 2022; 61: 135-141.
14.
Różycki M, Tomczak A. Zespół tylnej odwracalnej encefalopatii – opis przypadku. Pol Przegl Neurol 2018; 14: 244-248.
15.
Fugate JE, Rabinstein AA. Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions. Lancet Neurol 2015; 14: 914-925.
16.
Sudulagunta SR, Sodalagunta MB, Kumbhat M, Settikere Nataraju A. Posterior reversible encephalopathy syndrome(PRES). Oxf Med Case Reports 2017; 2017: omx011. DOI: 10.1093/omcr/omx011.
17.
Burnett MM, Hess CP, Roberts JP, Bass NM, Douglas VC, Josephson SA. Presentation of reversible posterior leukoencephalopathy syndrome in patients on calcineurin inhibitors. Clin Neurol Neurosurg 2010; 112: 886-891.
18.
Anderson RC, Patel V, Sheikh-Bahaei N, Liu CSJ, Rajamohan AG, Shiroishi MS, et al. Posterior reversible encephalopathy syndrome (PRES): pathophysiology and neuro-imaging. Front Neurol 2020; 11: 463. DOI: 10.3389/fneur.2020.00463.
19.
Pilato F, Distefano M, Calandrelli R. Posterior reversible encephalopathy syndrome and reversible cerebral vasoconstriction syndrome: clinical and radiological considerations. Front Neurol 2020; 11: 34. DOI: 10.3389/fneur.2020.00034.
20.
Fugate JE, Claassen DO, Cloft HJ, Kallmes DF, Kozak OS, Rabinstein AA. Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings. Mayo Clin Proc 2010; 85: 427-432.
21.
Hugonnet E, Da Ines D, Boby H, Claise B, Petitcolin V, Lannareix V, et al. Posterior reversible encephalopathy syndrome (PRES): features on CT and MR imaging. Diagn Interv Imaging 2013; 94: 45-52.
22.
Jordan A, Kinnucan J. Ustekinumab-associated posterior reversible encephalopathy syndrome in a patient with Crohn’s disease. ACG Case Rep 2022; 9: e00867. DOI: 10.14309/crj.0000000000000867.
23.
Mishra A, Seril DN. Posterior reversible encephalopathy syndrome following ustekinumab induction for Crohn’s disease. Case Rep Gastroenterol 2018; 12: 521-527.
24.
Papaconstantinou I, Mantzos DS, Pantiora E, Tasoulis MK, Vassilopoulou S, Mantzaris G. Posterior reversible encephalopathy syndrome following sepsis in a Crohn’s disease patient: a case report. World J Clin Cases 2016; 4: 103. DOI: 10.12998/wjcc.v4.i4.103.
25.
Haddock R, Garrick V, Horrocks I, Russell RK. A case of posterior reversible encephalopathy syndrome in a child with Crohn’s disease treated with Infliximab. J Crohns Colitis 2011; 5: 623-627.
26.
Chow S, Patnana S, Gupta NK. Posterior reversible encephalopathy syndrome in a patient with Crohn’s disease on infliximab. J Clin Gastroenterol 2016; 50: 687. DOI: 10.1097/mcg.0000000000000557.
27.
Cherian A, Soumya CV, Iype T, Mathew M, Sandeep P, Thadam JK, et al. Posterior reversible encephalopathy syndrome with PLEDs-plus due to mesalamine. J Neurosci Rural Pract 2014; 5: 72-75.
28.
Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 2006; 55: 749-753.
29.
Cichoz-Lach H. Esophageal Crohn disease. South Med J 2008; 101: 886. DOI: 10.1097/smj.0b013e3181806c65.
30.
Geboes K, De Hertogh G. Indeterminate colitis. Inflamm Bowel Dis 2003; 9: 324-331. DOI: 10.1097/00054725-200309000-00007.
31.
Wespi SP, Frei R, Sulz MC. A very rare cause of a relapsing para-oesophageal abscess. Case Rep Gastroenterol 2016; 10: 137-143.
32.
Wang W, Ni Y, Ke C, Cheng Q, Lu Q, Li X. Isolated Crohn’s disease of the esophagus with esophago-mediastinal fistula formation. World J Surg Oncol 2012; 10: 208. DOI: 10.1186/1477-7819-10-208.
33.
Tenorio Gallardo A, Quispe Mauricio AP, Joaquín Laguna A, Uribe Heredia M. Acute mediastinitis: what a radiologist need to know. European Congress of Radiology; 2017. Poster number: C-2519. DOI: 10.1594/ECR2017/C-2519.
34.
Akman C, Kantarci F, Cetinkaya S. Imaging in mediastinitis: a systematic review based on aetiology. Clin Radiol 2004; 59: 573-585.
35.
Exarhos DN, Malagari K, Tsatalou EG, Benakis SV, Peppas C, Kotanidou A, et al. Acute mediastinitis: spectrum of computed tomography findings. Eur Radiol 2005; 15: 1569-1574.
36.
Briggs KB, Rentea RM. Patent Urachus Apr 10. Treasure Island (FL): StatPearls Publishing; 2023.
37.
Parada Villavicencio C, Adam SZ, Nikolaidis P, Yaghmai V, Miller FH. Imaging of the urachus: Anomalies, complications, and mimics. Radiographics 2016; 36: 2049-2063.
38.
Solem CA, Loftus EV, Tremaine WJ, Pemberton JH, Wolff BG, Sandborn WJ. Fistulas to the urinary system in Crohn’s disease: clinical features and outcomes. Am J Gastroenterol 2002; 97: 2300-2305.
39.
Yu JS, Kim KW, Lee HJ, Lee YJ, Yoon CS, Kim MJ. Urachal remnant diseases: spectrum of CT and US findings. Radiographics 2001; 21: 451-461.
40.
Das JP, Vargas HA, Lee A, Hutchinson B, O’Connor E, Kok HK, et al. The urachus revisited: multimodal imaging of benign & malignant urachal pathology. Br J Radiol 2020; 93: 20190118. DOI: 10.1259/bjr.20190118.
Share
RELATED ARTICLE
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
